TY - JOUR T1 - Protective association of <em>HLA-DRB1</em>*04 subtypes in neurodegenerative diseases implicates acetylated Tau PHF6 sequences JF - medRxiv DO - 10.1101/2021.12.26.21268354 SP - 2021.12.26.21268354 AU - Yann Le Guen AU - Guo Luo AU - Aditya Ambati AU - Vincent Damotte AU - Iris Jansen AU - Eric Yu AU - Aude Nicolas AU - Itziar de Rojas AU - Thiago Peixoto Leal AU - Akinori Miyashita AU - Céline Bellenguez AU - Michelle Mulan Lian AU - Kayenat Parveen AU - Takashi Morizono AU - Hyeonseul Park AU - Benjamin Grenier-Boley AU - Tatsuhiko Naito AU - Fahri Küçükali AU - Seth D. Talyansky AU - Selina Maria Yogeshwar AU - Vicente Sempere AU - Wataru Satake AU - Victoria Alvarez AU - Beatrice Arosio AU - Michael E. Belloy AU - Luisa Benussi AU - Anne Boland AU - Barbara Borroni AU - María J. Bullido AU - Paolo Caffarra AU - Jordi Clarimon AU - Antonio Daniele AU - Daniel Darling AU - Stéphanie Debette AU - Jean-François Deleuze AU - Martin Dichgans AU - Carole Dufouil AU - Emmanuel During AU - Emrah Düzel AU - Daniela Galimberti AU - Guillermo Garcia-Ribas AU - José María García-Alberca AU - Pablo García-González AU - Vilmantas Giedraitis AU - Oliver Goldhardt AU - Caroline Graff AU - Edna Grünblatt AU - Olivier Hanon AU - Lucrezia Hausner AU - Stefanie Heilmann-Heimbach AU - Henne Holstege AU - Jakub Hort AU - Yoo Jin Jung AU - Deckert Jürgen AU - Silke Kern AU - Teemu Kuulasmaa AU - Ling Ling AU - Carlo Masullo AU - Patrizia Mecocci AU - Shima Mehrabian AU - Alexandre de Mendonça AU - Mercè Boada AU - Pablo Mir AU - Susanne Moebus AU - Fermin Moreno AU - Benedetta Nacmias AU - Gael Nicolas AU - Børge G. Nordestgaard AU - Goran Papenberg AU - Janne Papma AU - Lucilla Parnetti AU - Florence Pasquier AU - Pau Pastor AU - Oliver Peters AU - Yolande A.L. Pijnenburg AU - Gerard Piñol-Ripoll AU - Julius Popp AU - Laura Molina Porcel AU - Raquel Puerta AU - Jordi Pérez-Tur AU - Innocenzo Rainero AU - Inez Ramakers AU - Luis M Real AU - Steffi Riedel-Heller AU - Eloy Rodriguez-Rodriguez AU - Jose Luís Royo AU - Dan Rujescu AU - Nikolaos Scarmeas AU - Philip Scheltens AU - Norbert Scherbaum AU - Anja Schneider AU - Davide Seripa AU - Ingmar Skoog AU - Vincenzo Solfrizzi AU - Gianfranco Spalletta AU - Alessio Squassina AU - John van Swieten AU - Raquel Sánchez-Valle AU - Eng-King Tan AU - Thomas Tegos AU - Charlotte Teunissen AU - Jesper Qvist Thomassen AU - Lucio Tremolizzo AU - Martin Vyhnalek AU - Frans Verhey AU - Margda Waern AU - Jens Wiltfang AU - Jing Zhang AU - Henrik Zetterberg AU - Kaj Blennow AU - Julie Williams AU - Philippe Amouyel AU - Frank Jessen AU - Patrick G. Kehoe AU - Ole Andreassen AU - Cornelia Van Duin AU - Magda Tsolaki AU - Pascual Sánchez-Juan AU - Ruth Frikke-Schmidt AU - Kristel Sleegers AU - Tatsushi Toda AU - Anna Zettergren AU - Martin Ingelsson AU - EABD contributors AU - GR@ACE study group AU - DEGESCO consortium AU - DemGene AU - EADI AU - GERAD AU - Asian Parkinson’s Disease Genetics consortium AU - Yukinori Okada AU - Giacomina Rossi AU - Mikko Hiltunen AU - Jungsoo Gim AU - Kouichi Ozaki AU - Rebecca Sims AU - Jia Nee Foo AU - Wiesje van der Flier AU - Takeshi Ikeuchi AU - Alfredo Ramirez AU - Ignacio Mata AU - Agustín Ruiz AU - Ziv Gan-Or AU - Jean-Charles Lambert AU - Michael D. Greicius AU - Emmanuel Mignot Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/12/30/2021.12.26.21268354.abstract N2 - Using genome-wide association data, we analyzed Human Leukocyte Antigen (HLA) associations in over 176,000 individuals with Parkinson’s (PD) or Alzheimer’s (AD) disease versus controls across ancestry groups. A shared genetic association was observed across diseases at rs601945 (PD: odds ratio (OR)=0.84; 95% confidence interval, [0.80; 0.88]; p=2.2×10−13; AD: OR=0.91[0.89; 0.93]; p=1.8×10−22), and with a protective HLA association recently reported in amyotrophic lateral sclerosis (ALS). Hierarchical protective effects of HLA-DRB1*04 subtypes best accounted for the association, strongest with HLA-DRB1*04:04 and HLA-DRB1*04:07, intermediary with HLA-DRB1*04:01 and HLA-DRB1*04:03, and absent for HLA-DRB1*04:05. The same signal was associated with decreased neurofibrillary tangles (but not neuritic plaque density) in postmortem brains and was more strongly associated with Tau levels than Aβ42 levels in the cerebrospinal fluid. Finally, protective HLA-DRB1*04 subtypes strongly bound the aggregation-prone Tau PHF6 sequence, but only when acetylated at K311, a modification central to aggregation. An HLA-DRB1*04-mediated adaptive immune response, potentially against Tau, decreases PD, AD and ALS risk, offering the possibility of new therapeutic avenues.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Michael J. Fox Foundation grant MJFF-020161 (EM, ZGO), National Institute of Health and National Institute of Aging grants AG060747 (MDG), AG066206 (ZH), AG066515 (ZH, MDG), the European Union's Horizon 2020 research and innovation program under the Marie Skłodowska-Curie (grant agreement No. 890650, YLG), the Alzheimer's Association (AARF-20-683984, MEB), and the Iqbal Farrukh and Asad Jamal Fund, a grant from the EU Joint Programme - Neurodegenerative Disease Research (European Alzheimer DNA BioBank, EADB; JPND), the Japan Agency for Medical Research and Development (JP21dk0207045, TI), the Einstein Center for Neurosciences in Berlin (SMY). Inserm UMR1167 is also funded by the Inserm, Institut Pasteur de Lille, Lille Metropole Communaute Urbaine, and the French government's LABEX DISTALZ program (development of innovative strategies for a transdisciplinary approach to Alzheimer's disease). Additional funders of individual investigators and institutions who contributed to data collection and genotyping are provided in the Supplementary Materials.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study involves only openly available human data, which can be obtained from public repository (see Data availability statement). Participants or their caregivers provided written informed consent in the original studies. The current study protocol was granted an exemption by the Stanford University institutional review board because the analyses were carried out on deidentified, off-the-shelf data; therefore, additional informed consent was not required.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript Supplementary Tables. Data used in preparation of this manuscript can be obtained upon application at: - dbGaP (https://www.ncbi.nlm.nih.gov/gap/advanced_search/) - NIAGADS and NIAGADS DSS (https://www.niagads.org/) - LONI (https://ida.loni.usc.edu/) - Synapse (https://adknowledgeportal.synapse.org/) - RADC Rush (https://www.radc.rush.edu/) - NACC (https://naccdata.org/) - UK Biobank (biobank.ndph.ox.ac.uk/showcase/) https://www.ncbi.nlm.nih.gov/gap/advanced_search/ https://ida.loni.usc.edu/ https://adknowledgeportal.synapse.org/ https://www.radc.rush.edu/ https://naccdata.org/ ER -